Kenjiro Nagai | Respiratory | Research Excellence Award

Prof. Dr. Kenjiro Nagai | Respiratory | Research Excellence Award

Chairman | Ebino centro Clinic | Research Excellence Award

Dr. Nagai, Kenjiro is a clinician–researcher affiliated with Ebino Sentoro Clinic, Japan, specializing in infectious diseases, immunotherapy, and respiratory disorders, particularly virus-associated pulmonary complications. He has authored 19 Scopus-indexed publications and received over 565 citations, achieving an h-index of 11, which reflects sustained academic influence and research quality. With 41 co-authors, he maintains active multidisciplinary collaborations that enhance translational and clinical research outcomes. Among his notable contributions is an open-access case report published in BMJ Case Reports examining amplified natural killer cell therapy for HTLV-1–associated bronchiolitis and alveolar abnormalities. His work emphasizes innovative, evidence-based, and patient-centered therapeutic strategies. Through clinical scholarship, collaborative engagement, and translational application of immunotherapeutic approaches, Dr. Nagai contributes meaningfully to improving treatment outcomes and advancing global understanding of complex infectious and immune-mediated diseases.

Citation Metrics (Scopus)

565
400
300
150
0

Citations

565

Documents

19

h-index

11

Citations

Documents

h-index

View Scopus Profile

Featured Publication

Mahmoud Mansour | Pharmacology | Best Researcher Award

Prof. Mahmoud Mansour | Pharmacology | Best Researcher Award

Professor | King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Dr. Mahmoud Ahmed Mansour is a biomedical researcher affiliated with King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with recognized expertise in biochemical toxicology, oxidative stress, pharmacology, and cancer biology. His research primarily focuses on the molecular mechanisms of hepatocarcinogenesis, proteasome inhibition, antioxidant defense systems, and cardiometabolic complications. Dr. Mansour has authored 40 peer-reviewed publications, accumulating over 1,879 citations, with an h-index of 18, reflecting sustained scientific impact and scholarly influence. His highly cited works explore the antineoplastic potential of proteasome inhibitors such as carfilzomib, as well as oxidative stress in metabolic and reproductive health conditions. He has collaborated with more than 50 international co-authors, demonstrating strong interdisciplinary and cross-institutional engagement. The societal relevance of his research lies in advancing therapeutic strategies for cancer prevention, metabolic disorders, and drug-induced toxicity, contributing to improved clinical understanding and translational biomedical outcomes at a global level.

Citation Metrics (Scopus)

1879
1400
900
400
0

Citations

1,879

Documents

40

h-index

18

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Xin Li | Sports Medicine | Best Researcher Award

Assoc. Prof. Dr. Xin Li | Sports Medicine | Best Researcher Award

Associate Professor| Tianjin Normal University | China

Dr. Xin Li is an accomplished scholar and educator specializing in clinical medicine and sports health sciences, currently serving as an Associate Professor at Tianjin Normal University since 2006. She obtained her Doctor of Medicine (MD) in Clinical Medicine from Tianjin Medical University in July 2006. Over nearly two decades of academic and research experience, Dr. Li has established herself as a leading expert at the intersection of clinical medicine, exercise science, and health management. Her teaching portfolio encompasses a range of courses in sports health, exercise rehabilitation, and health management, with a focus on integrating clinical case studies into theoretical instruction to enhance students’ practical competencies and professional insight. Dr. Li’s research primarily addresses exercise interventions for chronic diseases, sports injury prevention, and rehabilitation science, contributing to the growing evidence base linking physical activity with disease prevention and functional recovery. She has led and participated in numerous provincial and municipal research projects, achieving notable outcomes that have advanced the application of medical principles in sports health practice. To date, Dr. Li has published over ten academic papers in peer-reviewed core journals and international conferences, several of which have been widely cited and recognized within the academic community for their methodological rigor and clinical relevance. Her collaborative approach bridges disciplines such as physiology, public health, and kinesiology, fostering innovation and interdisciplinary integration in sports medicine research. Beyond academia, Dr. Li’s work holds significant societal impact, promoting the scientific development of exercise-based health strategies for chronic disease management and population well-being. Combining solid clinical expertise, pedagogical excellence, and a strong research record, Dr. Xin Li continues to contribute meaningfully to the advancement of sports health education and evidence-based medical practice in China and beyond.

Profile: Scopus 

Featured Publications

Li, X. (2025). The influence of initial and final character positional probabilities on the flexibility of position coding in two-character word identification. Acta Psychologica Sinica.

Dr. Xin Li’s work bridges clinical medicine and sports science, advancing evidence-based approaches to exercise intervention, chronic disease prevention, and rehabilitation. Her research and teaching contribute to improving public health outcomes and enhancing human performance, promoting global innovation in integrated medical and sports health education.

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.